October 20, 2023 — Meilleur Technologies, Inc. announced a research collaboration agreement with the Alzheimer’s Disease ...
PET Imaging
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.
October 18, 2023 — The Centers for Medicare and Medicaid Services (CMS) announced it will no longer require coverage ...
October 11, 2023 — GE HealthCare today announced an exclusive global licensing agreement with SOFIE Biosciences (SOFIE) ...
Digital technology is opening remarkable opportunities for clinical positron emission tomography (PET) about which ...
October 11, 2023 — A new imaging agent, 68Ga-ABY-025, can predict early metabolic response to human epidermal growth ...
October 5, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...
September 28, 2023 — RefleXion Medical, a therapeutic oncology company, announced the company will showcase the ...
Precision can have an enormous impact on patients. From diagnosis to patient monitoring (see “How Digital PET/CT Can ...
Since the advent of the magnetic resonance imaging (MRI) exam on human patients in the late 1970s, this innovation ...
September 8, 2023 — Positron Corporation, a leading molecular imaging medical device company, is pleased to announce ...
September 7, 2023 — The groundbreaking AURA 10 specimen imager by Belgian MedTech pioneer XEOS has been cleared by the ...
PET is getting ready to venture outside oncology, cardiology and mainstream neurology. High on the list of new clinical ...
According to a new report from Transparency Market Research (TMR), PET radiotracers are expected to rise at a CAGR of 8 ...
July 28, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...
July 27, 2023 — Scientists have found a new use for copper in magnetic resonance imaging (MRI) contrast agent design ...
Analog is approximate. Digital is specific. Therein lies the fundamental difference between digital PET and its analog ...
July 26, 2023 — A molecular imaging tool developed by researchers at the University of California’s two nationally ...
July 25, 2023 — Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative ...
The healthcare market is witnessing a dynamic shift in how and where patients want to receive care, with the flexibility ...
July 11, 2023 — Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative ...
July 3, 2023 — RefleXion Medical, Inc., a therapeutic oncology company, today announced that results of a prospective ...
June 28, 2023 — A newly discovered radionuclide-based agent (CB-2PA-NT) has been shown to have high tumor uptake ...
June 28, 2023 — A novel PET perfusion radiotracer, 18F-flurpiridaz, can diagnose coronary artery disease (CAD) in obese ...
June 26, 2023 — Nizar A. Mullani, one of the pioneers of the first positron emission tomography (PET) prototype, has ...
October 20, 2023 